New brain scan could sharpen surgery for glioma patients
NCT ID NCT01165632
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested whether a special PET scan using 18F-FDOPA can help doctors better plan surgery and radiation for people with newly diagnosed brain tumors (gliomas). Twenty-four adults took part at Mayo Clinic. The goal was to see if the scan provides useful information beyond standard MRI, not to treat the tumor itself.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 18F-FDOPA (a radioactive tracer used in PET scans)
- What this could lead to
- If successful, this could improve how doctors plan surgery and radiation for brain tumors, potentially leading to more precise treatment.
- What could go wrong
- This is a very early pilot study with only 24 participants. It is designed to gather information, not to test a treatment. The results may not change current practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT ANAPLASTIC ASTROCYTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Could cutting a wider margin around brain tumors extend survival?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a 7-Week brain tumor treatment beat the standard 10-Week plan?
- Could a parasite drug fight childhood brain tumors?
- Could an antiparasitic drug boost radiation against childhood brain tumors?